A patient with asthma exacerbation presents with diffuse wheezing, low peak flow, and respiratory acidosis. After initiating treatment with nebulized bronchodilators and systemic corticosteroids, what is the nurse's priority action to evaluate the effectiveness of the interventions?

C) Assess the patient's oxygen saturation

A) Monitor the patient's blood pressure and heart rate

B) Check the patient's peak flow measurement

C) Assess the patient's oxygen saturation

D) Evaluate the patient's level of consciousness

A patient with asthma is experiencing an acute exacerbation characterized by wheezing, low oxygen saturation, and elevated eosinophil levels. Which nursing intervention is the highest priority at this time?

A) Administer nebulized bronchodilator treatment

B) Educate the patient on peak flow meter usage

C) Encourage oral fluid intake to thin secretions

D) Review the patient's long-term asthma management plan

A patient with asthma is showing signs of worsening respiratory acidosis and increasing respiratory distress despite initial treatment improvements. Which intervention would be most appropriate to address the current clinical findings?

B) Initiate non-invasive positive pressure ventilation (NPPV).

A) Increase the frequency of nebulized bronchodilator treatments.

B) Initiate non-invasive positive pressure ventilation (NPPV).

C) Administer an oral corticosteroid to reduce inflammation.

D) Provide supplemental oxygen to maintain SpO2 above 95%.

A patient with asthma is experiencing increasing respiratory distress despite initial improvements with nebulized bronchodilator treatments. Her ABG results indicate a worsening respiratory acidosis. What is the most appropriate nursing intervention to address her current condition?

B) Initiate non-invasive positive pressure ventilation

A) Increase the frequency of nebulized bronchodilator treatments

B) Initiate non-invasive positive pressure ventilation

C) Administer a dose of corticosteroids

D) Encourage deep breathing exercises to improve ventilation

A patient with an asthma exacerbation is on non-invasive positive pressure ventilation (NIPPV) but is showing signs of agitation and disorientation. Arterial blood gas analysis reveals a pH of 7.30, PaCO2 of 50 mmHg, and PaO2 of 65 mmHg. What is the most appropriate nursing intervention to prioritize at this time?

C) Prepare for possible intubation and mechanical ventilation

A) Increase the flow rate of oxygen on the NIPPV device

B) Administer a dose of a long-acting beta-agonist

C) Prepare for possible intubation and mechanical ventilation

D) Administer a systemic corticosteroid

A patient receiving non-invasive positive pressure ventilation (NIPPV) for acute respiratory distress remains agitated and disoriented with a blood gas showing a pH of 7.30, PaCO2 of 50 mmHg, and PaO2 of 65 mmHg. What is the priority nursing action to address this patient’s condition?

C) Re-evaluate the patient's ventilation settings and consider intubation

A) Increase the oxygen flow rate on the NIPPV

B) Administer a systemic corticosteroid as prescribed

C) Re-evaluate the patient's ventilation settings and consider intubation

D) Provide reassurance and reorient the patient

A patient with escalating respiratory distress and confirmed hypercapnia is under NIPPV and presents with signs of respiratory muscle fatigue and hypokalemia. As the nurse, which intervention should you prioritize to address the immediate needs of the patient?

B) Administer intravenous potassium supplementation to correct hypokalemia.

A) Increase the settings on the NIPPV to enhance ventilation.

B) Administer intravenous potassium supplementation to correct hypokalemia.

C) Initiate high-dose corticosteroid therapy to reduce inflammation.

D) Prepare for intubation and mechanical ventilation immediately.

A patient with escalating respiratory distress and signs of respiratory muscle fatigue is under non-invasive positive pressure ventilation (NIPPV). Despite interventions, her condition is not improving, and lab results indicate hypokalemia and possible infection. Which nursing intervention should take priority in addressing her immediate respiratory status?

D) Prepare for intubation and mechanical ventilation to secure the airway.

A) Increase the settings on the NIPPV to provide more ventilatory support.

B) Administer intravenous potassium to correct the hypokalemia.

C) Initiate broad-spectrum antibiotics to address the potential infection.

D) Prepare for intubation and mechanical ventilation to secure the airway.

A patient with a severe asthma exacerbation is showing signs of respiratory distress despite high-flow oxygen therapy. What is the most appropriate next step in the nursing care plan to address the patient's current condition?

B) Prepare for potential intubation and mechanical ventilation while continuing current therapies.

A) Increase the oxygen flow rate further to achieve higher saturation levels.

B) Prepare for potential intubation and mechanical ventilation while continuing current therapies.

C) Administer a bronchodilator via nebulizer to improve airway patency.

D) Initiate a continuous infusion of a sedative to reduce the patient's anxiety and respiratory effort.

A patient with a history of asthma is showing signs of respiratory distress despite initial interventions. Her oxygen saturation remains at 88% on high-flow oxygen, and her white blood cell count has increased. Given this scenario, what is the most appropriate nursing action to prioritize at this time?

B) Prepare for possible intubation by gathering necessary equipment and briefing the team.

A) Increase the oxygen flow rate to improve oxygen saturation.

B) Prepare for possible intubation by gathering necessary equipment and briefing the team.

C) Administer an additional dose of bronchodilator medication to relieve respiratory distress.

D) Reassess the patient’s vital signs and respiratory status in one hour to determine the next steps.

asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Asthma is characterized by chronic inflammation of the airways, which leads to hyperresponsiveness. This causes the bronchial tubes to constrict excessively in response to triggers such as allergens or irritants, leading to difficulty in breathing.

• Secondary mechanism: Inflammatory cells, including eosinophils and T-helper 2 lymphocytes, release cytokines and other mediators that exacerbate inflammation and contribute to airway remodeling. This remodeling includes thickening of the airway walls and increased mucus production, further obstructing airflow.

• Key complication: Persistent inflammation and airway remodeling can lead to irreversible changes, reducing lung function over time and increasing the frequency and severity of asthma attacks, highlighting the importance of early and consistent management.

Patient Profile

Demographics:

45-year-old female, office worker

History:

• Key past medical history: Diagnosed with asthma 10 years ago, history of seasonal allergies, mild hypertension

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler daily, Lisinopril 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing

• Key symptoms: Persistent cough, chest tightness, difficulty breathing during physical activity, frequent nighttime awakenings due to asthma symptoms

• Vital signs: Blood pressure 145/90 mmHg, heart rate 105 bpm, respiratory rate 24 breaths per minute, oxygen saturation 92% on room air, temperature 98.6°F

Section 1

As the healthcare team conducts an initial assessment, there are several critical findings. Upon auscultation, diffuse wheezing is noted throughout the lung fields, more pronounced on expiration, indicating significant bronchoconstriction. The patient reports using her rescue inhaler more frequently over the past few days, which suggests that her current maintenance therapy may be insufficient. A peak flow measurement reveals a reading of 200 L/min, significantly below her personal best of 350 L/min, indicating reduced airway function. Despite these efforts, her oxygen saturation remains low at 92% on room air, underscoring the severity of her current exacerbation.

In light of these findings, the clinical team orders a series of diagnostic tests. A chest X-ray is performed to rule out other causes of her symptoms, such as pneumonia or a pneumothorax, and reveals hyperinflation but no acute infiltrates. Blood tests, including a complete blood count (CBC) and serum eosinophil count, show an elevated eosinophil level, further confirming the inflammatory nature of her condition. The team considers the possibility of an exacerbation triggered by her seasonal allergies, which are known to worsen her asthma symptoms. Additionally, arterial blood gas (ABG) analysis reveals a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 65 mmHg, indicating respiratory acidosis and hypoxemia, necessitating more aggressive intervention.

Given these diagnostic insights, the team adjusts her treatment plan. She is initiated on a nebulized bronchodilator treatment and systemic corticosteroids to address the acute inflammation. The patient is also placed on supplemental oxygen to maintain adequate saturation levels. The healthcare provider discusses the need for further monitoring and potential adjustments to her long-term asthma management plan, such as a possible increase in her inhaled corticosteroid dosage or consideration of additional medications like leukotriene receptor antagonists to better control her symptoms and prevent future exacerbations. This comprehensive assessment and tailored intervention aim to stabilize her condition and improve her overall pulmonary function.

Section 2

As the patient continues to receive treatment, the healthcare team closely monitors her response to the interventions. Over the next few hours, the patient shows some improvement; her oxygen saturation increases to 95% on supplemental oxygen, and her wheezing diminishes slightly following nebulized bronchodilator treatments. However, despite these positive changes, she begins to exhibit signs of increasing respiratory distress. Her respiratory rate climbs to 28 breaths per minute, and she reports feeling more fatigued and short of breath. The patient's heart rate remains elevated at 110 beats per minute, suggesting persistent sympathetic nervous system activation due to inadequate oxygenation and increased work of breathing.

In response to these concerning developments, the clinical team decides to repeat the arterial blood gas analysis to assess the current state of her respiratory function. The results indicate a worsening respiratory acidosis, with a pH now at 7.28 and a PaCO2 level that has risen further to 52 mmHg, while the PaO2 remains low at 60 mmHg. These findings suggest that despite initial improvements, the patient's ventilation is not adequately clearing carbon dioxide, and her gas exchange is deteriorating. This prompts the team to consider the possibility of impending respiratory failure, necessitating a reevaluation of her treatment strategy.

Given these new complications, the healthcare team discusses the potential need for more intensive respiratory support, such as non-invasive positive pressure ventilation, to assist with her breathing and improve ventilation. Additionally, there is a consideration of increasing the frequency of her bronchodilator treatments and the possibility of adding a long-acting beta-agonist to her regimen. The patient's situation underscores the importance of continuous monitoring and dynamic adjustments to her management plan, highlighting the complex interplay between inflammation, bronchoconstriction, and ventilation in asthma management.

Section 3

As the clinical team shifts focus towards providing more intensive respiratory support, they implement non-invasive positive pressure ventilation (NIPPV) to help the patient manage her increased work of breathing and enhance alveolar ventilation. The addition of NIPPV is aimed at reducing her elevated PaCO2 levels and preventing further respiratory acidosis. Over the next hour, the team closely monitors her vital signs and performs serial arterial blood gas analyses to evaluate the effectiveness of this intervention. The patient’s respiratory rate gradually stabilizes to 24 breaths per minute, and there is a slight improvement in her oxygen saturation, now at 96% on NIPPV. These changes suggest a partial but promising response to the additional support.

Despite these early indications of stabilization, the patient starts to show new signs of potential complications. She becomes increasingly agitated and disoriented, which raises concerns about hypoxemia or hypercapnia affecting her neurological status. Her latest arterial blood gas results reveal a pH of 7.30, a PaCO2 that remains elevated at 50 mmHg, and a PaO2 that has slightly improved to 65 mmHg. These findings suggest that while there has been some improvement in oxygenation, ventilation remains inadequate and may be contributing to her altered mental status. The team is now faced with the challenge of optimizing her treatment to address both her respiratory and neurological symptoms effectively.

Given this evolving scenario, the healthcare team deliberates on the possible need for more aggressive interventions. They consider increasing the intensity of bronchodilator therapy, potentially incorporating a long-acting beta-agonist to sustain bronchodilation and reduce bronchospasm. Additionally, they explore the option of administering systemic corticosteroids to address underlying inflammation driving her asthma exacerbation. This critical juncture emphasizes the need for a thorough reassessment of the patient’s overall treatment strategy, ensuring that interventions are tailored to manage her symptoms while preventing further deterioration. The team remains vigilant, recognizing that timely adjustments in her management plan are crucial to improving her clinical outcomes and preventing the progression to acute respiratory failure.

Section 4

As the healthcare team continues to monitor the patient's response to the current treatment plan, they observe a change in her status that necessitates immediate attention. The patient’s agitation escalates, and she begins to exhibit signs of respiratory muscle fatigue, evident through the use of accessory muscles and an increase in her work of breathing. Her respiratory rate climbs back up to 30 breaths per minute, and her blood pressure rises to 150/95 mmHg, suggesting a sympathetic response to hypoxemic stress. Despite the use of NIPPV, her end-tidal CO2 levels remain elevated, confirming persistent hypercapnia and indicating that the current ventilation strategy may not be sufficient to effectively manage her respiratory distress.

In light of these findings, the team reviews the latest lab results, which show a white blood cell count of 15,000/mm³, hinting at a possible infectious process contributing to her deteriorating condition. Furthermore, her electrolytes reveal a slight hypokalemia with a potassium level of 3.2 mEq/L, potentially exacerbating her muscle weakness and contributing to her increased respiratory effort. The combination of these factors prompts the team to consider additional interventions, including the administration of systemic corticosteroids to address both inflammation and potential infection, as well as electrolyte replacement therapy to correct her hypokalemia and support muscle function.

This evolving situation challenges the team to apply clinical reasoning to balance the need for aggressive treatment with the potential risks associated with increased medication use. They decide to initiate a low-dose corticosteroid regimen and supplement potassium intravenously, monitoring her closely for any adverse reactions. The team remains vigilant, fully aware that these interventions are critical to preventing further complications and stabilizing her condition. As they proceed, they prepare for the possibility of escalating care, including potential intubation, should her respiratory status fail to improve with these measures.

Section 5

As the healthcare team implements the new interventions, they closely monitor the patient's response. Within the first hour, there is a modest improvement in her respiratory rate, which decreases to 26 breaths per minute. However, her use of accessory muscles persists, indicating ongoing respiratory distress. Her blood pressure shows slight improvement, lowering to 145/90 mmHg, suggesting some relief of the sympathetic response. Despite these changes, the patient's oxygen saturation remains concerning at 88% on the current high-flow oxygen delivery system, prompting the team to consider further escalation of care.

The follow-up laboratory results reveal a slight improvement in her potassium levels, now at 3.5 mEq/L, indicating that the electrolyte replacement therapy is beginning to take effect. However, the patient's white blood cell count has risen further to 17,000/mm³, strengthening the suspicion of an underlying infectious process. The team decides to add a broad-spectrum antibiotic to her treatment regimen, recognizing the need to address the potential infection that may be exacerbating her asthma exacerbation.

Despite these efforts, the patient's condition remains fragile, and the team anticipates the possibility of intubation if her respiratory status does not stabilize soon. They prepare for this potential intervention by discussing with the patient and her family the rationale and risks associated with mechanical ventilation. This step emphasizes the importance of shared decision-making in critical care settings. The team remains committed to reevaluating her status frequently, ready to adjust the treatment plan as her clinical picture continues to evolve.